ProCE Banner Activity

19-28z CAR T-Cell Efficacy and Toxicity in Adults With R/R B-Cell ALL

Slideset Download
Conference Coverage
Preinfusion disease burden associated with increased rates of cytokine release syndrome after 19-28z CAR-modified T-cell therapy.

Released: June 06, 2016

Expiration: June 05, 2017

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Ariad

Bayer Healthcare Pharma

Celgene

Genentech Roche Virology

Incyte

Merck Oncology

Taiho Pharmaceuticals